- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharma’s Missing Out on Social Media Says Worldcom Report
The Worldcom Public Relations Group, a global partnership of independent public relations firms, conducted research that suggests many large pharmaceutical companies are not taking advantage of online and social media communications. The report, Digital Health Monitor, identifies how 25 global pharma firms manage their online and social media presence globally and in 20 countries.
The report ranks each company in terms of their presence on, and the use of, Apps, Blogs Facebook, Flickr, Instagram, LinkedIn, Pinterest, Tumblr, Twitter and YouTube. It also reviewed the use of these channels by country. Pfizer, for example, came out on top for the use of YouTube, while Novartis ranked as top user for LinkedIn. The report found, however, that none of the companies used these channels to maximum advantage.
Download the full report here.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
